Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor, Inc. (NYSE: OMI) is set to announce its financial results for the fourth quarter and full year of 2022 on February 28, 2023, before market opening. A conference call for investors and analysts will follow at 8:00 a.m. ET. Participants can join via a toll-free phone line or through a live webcast on the company’s investor relations page. Owens & Minor is a leading healthcare solutions provider with a focus on supply chain management, PPE manufacturing, and home health services. The company has been operational since 1882 and employs over 20,000 people globally.
Owens & Minor (NYSE: OMI) will participate in a virtual fireside chat at the 5th Annual Evercore ISI HealthCONx Conference. The event is scheduled for November 30 at 1:00 p.m. Eastern Time. Interested parties can register for the live webcast via the investor relations page of the company’s website. A replay will be available post-presentation.
Owens & Minor is a global healthcare solutions provider focusing on product manufacturing and delivery, home health supply, and perioperative services since 1882. The company is headquartered in Richmond, Virginia, with over 20,000 employees.
The Owens & Minor Foundation has partnered with Ronald McDonald House Charities (RMHC) as its first flagship charity, contributing
Owens & Minor, Inc. (NYSE-OMI) reported Q3 2022 results with revenue of $2.5 billion, slightly down from $2.5 billion in Q3 2021. Patient Direct revenue surged by 142% to $594 million, driven by the Apria acquisition. Adjusted EBITDA rose to $127 million, reflecting a 140 basis point margin increase. The company generated $69 million in cash from operations during the quarter. Looking forward, 2022 revenue is forecasted between $9.8 billion and $10.0 billion, with adjusted EPS projected between $2.50 and $2.60. Operational challenges are noted as acute care customers delay reorders.
The Owens & Minor Foundation has announced a $100,000 donation to the National Association of Free and Charitable Clinics (NAFC) to support programs enhancing health equity. This contribution strengthens the foundation's commitment to fostering healthier communities and aligns with NAFC's mission to provide affordable healthcare access to the medically underserved. The donation follows an earlier contribution of $10,000 to assist clinics in Florida affected by Hurricane Ian, reflecting the foundation's ongoing efforts in community support.
Owens & Minor (NYSE:OMI) announced executive changes, with Andrew G. Long appointed as EVP and CEO of the Products & Healthcare Services segment, succeeding Jeffrey T. Jochims. Alexander J. Bruni will take over as EVP and CFO. The company provided preliminary third-quarter financial results, estimating GAAP net income per share between $0.15 and $0.17, and adjusted net income per share between $0.39 and $0.41. Additionally, 2022 guidance was updated, projecting adjusted net income per share to range from $2.50 to $2.60, down from $2.85 to $3.15.
Owens & Minor has received two 2022 Supplier Awards from Vizient, recognizing its commitment to service excellence. The Medical/Surgical Supplier Excellence Award and the Achieve Committed Program Excellence Award for the HALYARD product brand were announced at the Vizient Connections Summit held on September 19-22. These awards highlight Owens & Minor’s performance in cost management and supply chain efficiency, reinforcing their value in healthcare support.
Owens & Minor (NYSE: OMI) announced its participation in the 2022 Baird Global Healthcare Conference on Tuesday, September 13, at 12:15 p.m. EDT. Investors can view the live webcast by visiting the investor relations page on the Owens & Minor website at least ten minutes prior to the presentation. A replay will also be available afterwards. Established in 1882 and headquartered in Richmond, Va., Owens & Minor is a Fortune 500 healthcare solutions company focused on product manufacturing, delivery, and perioperative services, employing over 20,000 team members globally.
Owens & Minor (NYSE: OMI) and Allina Health announced a renewed partnership focused on creating an integrated service model aimed at enhancing supply chain resiliency. This collaboration, evolving from a 20-year relationship, will establish a centralized service center to improve inventory management and communication across Allina Health's network, which includes over 6,000 physicians. The initiative aims to lower inventory costs while increasing transparency and efficiency, ensuring clinical staff receive necessary products promptly.
Owens & Minor reported Q2 2022 results with revenue of $2.5 billion and adjusted EBITDA of $156 million, reflecting a 145% increase in Patient Direct revenue. Despite success in its business segments, the company revised its full-year outlook with adjusted EPS projected between $2.85 and $3.15 due to weak hospital volumes and economic challenges. Key highlights include strong performance from the Byram business and successful integration of Apria, though macroeconomic headwinds and lower elective procedure volumes raised concerns about future growth.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
What does Owens & Minor, Inc. do?
Where is Owens & Minor headquartered?
What are the main segments of Owens & Minor's business?
Who are Owens & Minor's customers?
How much revenue does Owens & Minor generate annually?
What regions do Owens & Minor serve?
What recent achievements has Owens & Minor accomplished?
What is the focus of the Products & Healthcare Services segment?
What does the Patient Direct segment do?